ÂÜÀòÂÒÂ×

Fabrice Chouraqui serves as the Chief Executive Officer of Cellarity since May 2020 and also holds the position of CEO Partner at Flagship Pioneering. In addition, Fabrice Chouraqui is a Board Member at Orano Med, starting in September 2022. Previously, Fabrice Chouraqui had an extensive career at Novartis, culminating as President of Novartis Pharmaceuticals US, with roles spanning Latin America and Canada, Global Head of Neuroscience, and General Manager in Belgium. At Bristol-Myers Squibb, experiences included Vice President of Commercial Operations for Asia Pacific and General Manager roles in South East Asia, the United Kingdom, and Denmark, alongside managing marketing and product responsibilities. Professional beginnings included positions at Hoechst Marion Roussel Inc. in project management. Educational qualifications encompass an MBA in Finance from INSEAD, a PharmD from Université Paris Cité, a postgraduate degree in Quality Assurance of Medicines, and an MSc in Biological and Medicinal Sciences from the same institution.